Hervycta 150mg Injection: Effective Treatment Solution

Uses:

• Advanced and metastatic breast cancer;
• Metastatic gastric cancer.

Mechanism of action:

• The drug selectively binds to HER2 proteins, which are overexpressed in certain cancer cells, and stops their growth.

Important information:

• Not recommended for patients under 18, those with severe breathing problems, or those needing oxygen treatment.
• Inform your physician about all medications, including supplements and herbal medicines, before starting treatment.
• Keep out of sight and reach of children.
• Store between 2˚C and 8˚C.

Administration:

• Administered intravenously for 90 minutes, then within 30 minutes for subsequent doses if well tolerated.
• Administered before or after surgery.

Safety advice:

• Pregnancy: discuss with your physician before taking.
• Breastfeeding: avoid breastfeeding while on treatment and for at least seven months after the final dose.
• Lungs: consult your doctor if you have any lung conditions before starting treatment.
• Liver: inform your physician if you have any liver disorders.
• Alcohol: consult your doctor to know if it is safe to consume alcohol while on treatment.
• Driving: avoid driving or handling machinery during treatment due to possible side effects like dizziness and tiredness.

Side effects:

• Serious: heart problems, allergic reactions, kidney problems, breathing difficulties.
• Common: fever, visual disturbances, nose bleeds or runny nose, hair loss, dizziness, nail disorders, weight loss, loss of appetite, bruising, dry mouth, liver inflammation, muscle pain, asthma/lung disorders.

FAQ:

• Q1: Is Hervycta 150mg Injection used as a monotherapy in treating breast cancer?
  • A1: No, it is generally given along with chemotherapy medications such as paclitaxel or docetaxel or platinum compounds. Sometimes it is also given with hormonal agents for those patients with elevated hormonal status.
• Q2: Does Hervycta 150mg Injection cause heart problems?
  • A2: Yes, it can damage the heart muscles. Heart check-ups are advised every 3 months and continued for 2-5 years after treatment completion.
• Q3: Can I breastfeed while on treatment with Hervycta 150mg Injection?
  • A3: No, it is unsafe to breastfeed while on treatment and for at least seven months after the last dose.
• Q4: Can Hervycta 150mg Injection be consumed during pregnancy?
  • A4: No, it is unsafe to consume Hervycta 150mg Injection while pregnant as it can harm the baby. Discuss birth control methods with your physician.

Fact box:

• Molecule name: Trastuzumab.
• Therapeutic class: Anti-cancer.
• Pharmacological class: HER2 inhibitor.
• Indications:
  • Advanced and metastatic breast cancer;
  • Metastatic gastric cancer.

Tags: medical-injection, hervycta, drug, pharmaceutical, 150mg